SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

IDEXX Laboratories, Inc. – ‘10-K’ for 12/31/23 – ‘EX-32.1’

On:  Thursday, 2/22/24, at 4:17pm ET   ·   For:  12/31/23   ·   Accession #:  874716-24-57   ·   File #:  0-19271

Previous ‘10-K’:  ‘10-K’ on 2/16/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/22/24  IDEXX Laboratories, Inc.          10-K       12/31/23  140:15M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.96M 
 2: EX-10.28    Material Contract                                   HTML     45K 
 3: EX-10.50    Material Contract                                   HTML     79K 
 4: EX-21       Subsidiaries List                                   HTML     48K 
 5: EX-23       Consent of Expert or Counsel                        HTML     37K 
10: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     64K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     42K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     42K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     38K 
16: R1          Cover Page                                          HTML    103K 
17: R2          Audit Information                                   HTML     42K 
18: R3          Consolidated Balance Sheets                         HTML    167K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
20: R5          Consolidated Statements of Income                   HTML    138K 
21: R6          Consolidated Statements of Comprehensive Income     HTML     95K 
22: R7          Consolidated Statements of Comprehensive Income     HTML     56K 
                (Parenthetical)                                                  
23: R8          Consolidated Statements of Stockholders? Equity     HTML    101K 
24: R9          Consolidated Statements of Stockholders? Equity     HTML     39K 
                (Parenthetical)                                                  
25: R10         Consolidated Statements of Cash Flows               HTML    126K 
26: R11         Nature of Business, Basis of Presentation and       HTML     43K 
                Principles of Consolidation                                      
27: R12         Summary of Significant Accounting Policies          HTML     64K 
28: R13         Revenue                                             HTML    140K 
29: R14         Acquisitions, Asset Purchases and Investments       HTML     54K 
30: R15         Share-Based Compensation                            HTML    108K 
31: R16         Credit Losses                                       HTML     44K 
32: R17         Inventories                                         HTML     47K 
33: R18         Leases                                              HTML     58K 
34: R19         Property and Equipment, Net                         HTML     72K 
35: R20         Other Current and Long-Term Assets                  HTML     60K 
36: R21         Goodwill and Intangible Assets, Net                 HTML    107K 
37: R22         Accounts Payable, Accrued Liabilities and Other     HTML     63K 
                Long-Term Liabilities                                            
38: R23         Debt                                                HTML     91K 
39: R24         Income Taxes                                        HTML    147K 
40: R25         Earnings Per Share                                  HTML     57K 
41: R26         Commitments, Contingencies and Guarantees           HTML     45K 
42: R27         Segment Reporting                                   HTML    129K 
43: R28         Fair Value Measurements                             HTML    111K 
44: R29         Hedging Instruments                                 HTML     99K 
45: R30         Repurchases of Common Stock                         HTML     62K 
46: R31         Accumulated Other Comprehensive Income              HTML    101K 
47: R32         Preferred Stock                                     HTML     39K 
48: R33         Idexx Retirement and Incentive Savings Plan         HTML     50K 
49: R34         Pay vs Performance Disclosure                       HTML     49K 
50: R35         Insider Trading Arrangements                        HTML     43K 
51: R36         Summary of Significant Accounting Policies          HTML    169K 
                (Policies)                                                       
52: R37         Revenue (Tables)                                    HTML    103K 
53: R38         Share-Based Compensation (Tables)                   HTML     99K 
54: R39         Inventories (Tables)                                HTML     46K 
55: R40         Leases (Tables)                                     HTML     56K 
56: R41         Property and Equipment, Net (Tables)                HTML     73K 
57: R42         Other Current and Long-Term Assets (Tables)         HTML     61K 
58: R43         Goodwill and Intangible Assets, Net (Tables)        HTML    109K 
59: R44         Accounts Payable, Accrued Liabilities and Other     HTML     66K 
                Long-Term Liabilities (Tables)                                   
60: R45         Debt (Tables)                                       HTML     72K 
61: R46         Income Taxes (Tables)                               HTML    148K 
62: R47         Earnings Per Share (Tables)                         HTML     57K 
63: R48         Segment Reporting (Tables)                          HTML    126K 
64: R49         Fair Value Measurements (Tables)                    HTML    104K 
65: R50         Hedging Instruments (Tables)                        HTML     87K 
66: R51         Repurchases of Common Stock (Tables)                HTML     60K 
67: R52         Accumulated Other Comprehensive Income (Tables)     HTML    103K 
68: R53         Idexx Retirement and Incentive Savings Plan         HTML     44K 
                (Tables)                                                         
69: R54         Summary of Significant Accounting Policies          HTML     49K 
                (Details)                                                        
70: R55         Revenue (Revenue Recognition) (Details)             HTML     42K 
71: R56         Revenue (Disaggregation of Revenue by Major         HTML     73K 
                Product and Service Categories) (Details)                        
72: R57         Revenue (Disaggregation of Revenue by Principal     HTML     83K 
                Geographic Area, Based on Customers' Domiciles)                  
                (Details)                                                        
73: R58         Revenue (Product and Service Terms) (Details)       HTML     48K 
74: R59         Revenue (Free or Discounted Instruments and         HTML     43K 
                Systems) (Details)                                               
75: R60         Revenue (Up-Front Consideration Paid to Customers)  HTML     42K 
                (Details)                                                        
76: R61         Revenue (Rebate Arrangements) (Details)             HTML     47K 
77: R62         Revenue (Remaining Performance Obligation)          HTML     81K 
                (Details)                                                        
78: R63         Revenue (Instrument Rental Arrangements) (Details)  HTML     39K 
79: R64         Revenue (Reagent Rental Arrangements) (Details)     HTML     50K 
80: R65         Revenue (Deferred Extended Warranties and           HTML     45K 
                Post-Contract Support Revenue) (Details)                         
81: R66         Revenue (Costs to Obtain a Contract) (Details)      HTML     47K 
82: R67         Acquisitions, Asset Purchases and Investments       HTML    177K 
                (Details)                                                        
83: R68         Share-Based Compensation (Narrative) (Details)      HTML    121K 
84: R69         Share-Based Compensation (Schedule of Selected      HTML     60K 
                Financial Impact of Share-Based Compensation)                    
                (Details)                                                        
85: R70         Share-Based Compensation (Schedule of Weighted      HTML     46K 
                Averages of the Assumptions Used In Estimating the               
                Fair Value of Stock Option Awards) (Details)                     
86: R71         Share-Based Compensation (Schedule of Stock Option  HTML     91K 
                Activity) (Details)                                              
87: R72         Share-Based Compensation (Schedule Of Restricted    HTML     57K 
                Stock Unit Activity) (Details)                                   
88: R73         Credit Losses (Details)                             HTML     51K 
89: R74         Inventories (Narrative) (Details)                   HTML     44K 
90: R75         Inventories (Schedule of Components of              HTML     46K 
                Inventories) (Details)                                           
91: R76         Leases (Narrative) (Details)                        HTML     44K 
92: R77         Leases (Maturities of Operating Lease Liabilities)  HTML     61K 
                (Details)                                                        
93: R78         Leases (Supplemental Cash Flow Information)         HTML     41K 
                (Details)                                                        
94: R79         Property and Equipment, Net (Schedule of Estimated  HTML     52K 
                Useful Lives) (Details)                                          
95: R80         Property and Equipment, Net (Schedule of Property   HTML     60K 
                and Equipment) (Details)                                         
96: R81         Property and Equipment, Net (Summary Of             HTML     51K 
                Depreciation And Amortization, Capitalized                       
                Computer Software For Internal Use And Unpaid                    
                Property Equipment Reflected In Account Payable                  
                And Accrued Expenses) (Details)                                  
97: R82         Property and Equipment, Net (Narrative) (Details)   HTML     39K 
98: R83         Other Current and Long-Term Assets (Schedule of     HTML     50K 
                Other Current Assets) (Details)                                  
99: R84         Other Current and Long-Term Assets (Schedule Of     HTML     51K 
                Other Long-term Assets) (Details)                                
100: R85         Goodwill and Intangible Assets, Net (Narrative)     HTML     45K  
                (Details)                                                        
101: R86         Goodwill and Intangible Assets, Net (Schedule of    HTML     58K  
                Goodwill) (Details)                                              
102: R87         Goodwill and Intangible Assets, Net (Schedule of    HTML     49K  
                Estimated Useful Lives For Intangible Assets)                    
                (Details)                                                        
103: R88         Goodwill and Intangible Assets, Net (Schedule of    HTML     53K  
                Intangible Assets Other Than Goodwill) (Details)                 
104: R89         Goodwill and Intangible Assets, Net (Schedule of    HTML     52K  
                Expected Amortization Expense) (Details)                         
105: R90         Accounts Payable, Accrued Liabilities and Other     HTML     48K  
                Long-Term Liabilities (Schedule of Supplier                      
                Financing Program) (Details)                                     
106: R91         Accounts Payable, Accrued Liabilities and Other     HTML     52K  
                Long-Term Liabilities (Schedule of Accrued                       
                Liabilities) (Details)                                           
107: R92         Accounts Payable, Accrued Liabilities and Other     HTML     43K  
                Long-Term Liabilities (Schedule Of Other Long-term               
                Liabilities) (Details)                                           
108: R93         Debt (Narrative) (Details)                          HTML    201K  
109: R94         Debt (Schedule of Current Senior Notes              HTML     78K  
                Outstanding) (Details)                                           
110: R95         Debt (Schedule of Future Maturities of Long-Term    HTML     57K  
                Debt) (Details)                                                  
111: R96         Income Taxes (Schedule of Earnings Before Income    HTML     46K  
                Taxes) (Details)                                                 
112: R97         Income Taxes (Schedule of Components of Provision   HTML     65K  
                (Benefit) for Income Taxes) (Details)                            
113: R98         Income Taxes (Schedule of Effective Income Tax      HTML     57K  
                Rate Reconciliation) (Details)                                   
114: R99         Income Taxes (Narrative) (Details)                  HTML     53K  
115: R100        Income Taxes (Schedule of Components of Net         HTML     91K  
                Deferred Tax Assets and Liabilities) (Details)                   
116: R101        Income Taxes (Schedule of Valuation Allowance For   HTML     45K  
                Deferred Tax Assets) (Details)                                   
117: R102        Income Taxes (Schedule of Changes in Unrecognized   HTML     49K  
                Tax Benefits) (Details)                                          
118: R103        Earnings Per Share (Schedule of Reconciliation of   HTML     47K  
                Shares Outstanding for Basic and Diluted Earnings                
                Per Share) (Details)                                             
119: R104        Earnings Per Share (Schedule of Number of           HTML     44K  
                Anti-Dilutive Stock Options and Awards) (Details)                
120: R105        Commitments, Contingencies and Guarantees           HTML     48K  
                (Details)                                                        
121: R106        Segment Reporting (Narrative) (Details)             HTML     38K  
122: R107        Segment Reporting (Summary of Segment Performance)  HTML     99K  
                (Details)                                                        
123: R108        Segment Reporting (Schedule of Net Long-Lived       HTML     71K  
                Assets by Principal Geographic Areas) (Details)                  
124: R109        Fair Value Measurements (Narrative) (Details)       HTML     55K  
125: R110        Fair Value Measurements (Schedule of Assets and     HTML    112K  
                Liabilities) (Details)                                           
126: R111        Fair Value Measurements (Schedule of Contingent     HTML     47K  
                Consideration Liability) (Details)                               
127: R112        Hedging Instruments (Narrative) (Details)           HTML    108K  
128: R113        Hedging Instruments (Derivatives Designated in      HTML     57K  
                Cash Flow Hedging Relationships) (Details)                       
129: R114        Hedging Instruments (Schedule of Fair Values and    HTML     76K  
                Balance Sheet Classifications of Derivatives                     
                Designated as Hedging Instruments) (Details)                     
130: R115        Repurchases of Common Stock (Details)               HTML     59K  
131: R116        Accumulated Other Comprehensive Income (Schedule    HTML     87K  
                of AOCI) (Details)                                               
132: R117        Accumulated Other Comprehensive Income (Schedule    HTML     77K  
                of Reclassifications out of AOCI) (Details)                      
133: R118        Preferred Stock (Details)                           HTML     44K  
134: R119        Idexx Retirement and Incentive Savings Plan         HTML     55K  
                (Narrative) (Details)                                            
135: R120        Idexx Retirement and Incentive Savings Plan         HTML     52K  
                (Schedule of Future Benefits Expected to be Paid)                
                (Details)                                                        
137: XML         IDEA XML File -- Filing Summary                      XML    268K  
140: XML         XBRL Instance -- idxx-20231231_htm                   XML   3.62M  
136: EXCEL       IDEA Workbook of Financial Report Info              XLSX    295K  
12: EX-101.CAL  XBRL Calculations -- idxx-20231231_cal               XML    310K 
13: EX-101.DEF  XBRL Definitions -- idxx-20231231_def                XML    973K 
14: EX-101.LAB  XBRL Labels -- idxx-20231231_lab                     XML   2.86M 
15: EX-101.PRE  XBRL Presentations -- idxx-20231231_pre              XML   1.76M 
11: EX-101.SCH  XBRL Schema -- idxx-20231231                         XSD    275K 
138: JSON        XBRL Instance as JSON Data -- MetaLinks              789±  1.18M  
139: ZIP         XBRL Zipped Folder -- 0000874716-24-000057-xbrl      Zip    754K  


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED BY
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the report on Form 10-K of IDEXX Laboratories, Inc. (the “Company”) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002, that:


(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Jonathan J. Mazelsky
February 22, 2024Jonathan J. Mazelsky
President and Chief Executive Officer


A signed original of this written statement required by Section 906, has been provided to IDEXX Laboratories, Inc. and will be retained by IDEXX Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/22/24None on these Dates
For Period end:12/31/23
 List all Filings 


30 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/01/23  IDEXX Laboratories, Inc.          10-Q        9/30/23  102:9.6M
10/21/22  IDEXX Laboratories, Inc.          8-K:1,2,9  10/20/22   11:1.3M                                   Donnelley … Solutions/FA
 7/15/22  IDEXX Laboratories, Inc.          8-K:5,9     7/13/22   12:558K
 5/04/22  IDEXX Laboratories, Inc.          10-Q        3/31/22  100:8.3M
 2/16/22  IDEXX Laboratories, Inc.          10-K       12/31/21  151:18M
12/09/21  IDEXX Laboratories, Inc.          8-K:1,2,9  12/09/21   11:1.2M                                   Donnelley … Solutions/FA
11/02/21  IDEXX Laboratories, Inc.          10-Q        9/30/21   98:9.8M
 5/04/21  IDEXX Laboratories, Inc.          10-Q        3/31/21   94:7.7M
 2/12/21  IDEXX Laboratories, Inc.          10-K       12/31/20  131:15M
10/29/20  IDEXX Laboratories, Inc.          10-Q        9/30/20   98:10M
 4/30/20  IDEXX Laboratories, Inc.          10-Q        3/31/20  101:9.4M
 4/16/20  IDEXX Laboratories, Inc.          8-K:1,2,9   4/10/20   15:2.2M                                   ActiveDisclosure/FA
 3/27/20  IDEXX Laboratories, Inc.          8-K:1,2,9   3/23/20   11:294K                                   ActiveDisclosure/FA
 2/14/20  IDEXX Laboratories, Inc.          10-K       12/31/19  139:18M
10/24/19  IDEXX Laboratories, Inc.          8-K:5,7,9  10/23/19   14:662K                                   Toppan Merrill/FA
 3/15/19  IDEXX Laboratories, Inc.          8-K:1,2,9   3/14/19    3:1.3M
 2/15/19  IDEXX Laboratories, Inc.          10-K       12/31/18  139:17M
 3/29/18  IDEXX Laboratories, Inc.          DEF 14A     5/09/18    1:3M                                     DG3/FA
 2/16/18  IDEXX Laboratories, Inc.          10-K       12/31/17  135:20M
 2/17/16  IDEXX Laboratories, Inc.          10-K       12/31/15  120:19M
 6/24/15  IDEXX Laboratories, Inc.          8-K:1,2,9   6/18/15    2:793K                                   Donnelley … Solutions/FA
 7/25/14  IDEXX Laboratories, Inc.          8-K:1,2,9   7/21/14    3:1M                                     Donnelley … Solutions/FA
12/30/13  IDEXX Laboratories, Inc.          S-8        12/30/13    4:134K                                   Donnelley … Solutions/FA
12/12/13  IDEXX Laboratories, Inc.          8-K:1,2,9  12/11/13    2:404K                                   Donnelley … Solutions/FA
 7/23/13  IDEXX Laboratories, Inc.          10-Q        6/30/13  140:15M
 7/23/10  IDEXX Laboratories, Inc.          10-Q        6/30/10   38:5.6M                                   Toppan Merrill/FA
 2/19/10  IDEXX Laboratories, Inc.          10-K       12/31/09    9:1.2M                                   Donnelley … Solutions/FA
 2/27/08  IDEXX Laboratories, Inc.          10-K       12/31/07   14:1.2M                                   Bowne - BPC/FA
 8/03/06  IDEXX Laboratories, Inc.          10-Q        6/30/06    7:1.5M
11/14/02  IDEXX Laboratories, Inc.          10-Q        9/30/02    2:225K
Top
Filing Submission 0000874716-24-000057   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 8:55:14.1am ET